Literature DB >> 18976447

Distribution of killer cell immunoglobulin-like receptor genes in Poles.

E Majorczyk1, W Łuszczek, I Nowak, A Pawlik, A Wiśniewski, M Jasek, P Kuśnierczyk.   

Abstract

Killer cell immunoglobulin-like receptors (KIRs) present on natural killer cells and minor subpopulations of T cells recognize class I human leucocyte antigen (HLA) molecules on the surface of target cells. Humans differ by the presence or absence of some KIR genes on their chromosomes. As KIRs are important for the outcome of tissue transplantation (particularly for haematopoietic stem cell transplantation) and possibly for pregnancy and autoimmune diseases, knowledge of the KIR gene distribution in a given human population is of practical value. Therefore, we tested 363 healthy individuals from Western Poland for the presence or absence of KIR genes. Results are compared with those published for other human populations. KIR gene frequencies in Poles are close to these in other Caucasoids but different from those in Asian and African populations, and particularly distant from those in Australian Aborigines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976447     DOI: 10.1111/j.1744-313X.2008.00792.x

Source DB:  PubMed          Journal:  Int J Immunogenet        ISSN: 1744-3121            Impact factor:   1.466


  2 in total

1.  Killer cell immunoglobulin-like receptor gene diversity in the Saudi population.

Authors:  Ameera Gaafar; Atia Sheereen; Alia Iqneibi; Gamal Mohamed; Abdullah Al Sulaiman; Hannu Turpeinen; Khalid Al Hussein
Journal:  Mol Biol Rep       Date:  2010-11-24       Impact factor: 2.316

2.  Allele-level haplotype frequencies and pairwise linkage disequilibrium for 14 KIR loci in 506 European-American individuals.

Authors:  Cynthia Vierra-Green; David Roe; Lihua Hou; Carolyn Katovich Hurley; Raja Rajalingam; Elaine Reed; Tatiana Lebedeva; Neng Yu; Mary Stewart; Harriet Noreen; Jill A Hollenbach; Lisbeth A Guethlein; Tao Wang; Stephen Spellman; Martin Maiers
Journal:  PLoS One       Date:  2012-11-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.